Article

Study uses MRI to assess mechanisms in IIH

Measures of total cranial, ventricular, and extraventricular cerebrospinal fluid (CSF) volumes in idiopathic intracranial hypertension (IIH) provide strong evidence that at least two mechanisms are involved in this condition, said Byron L. Lam, MD.

Fort Lauderdale, FL-Measures of total cranial, ventricular, and extraventricular cerebrospinal fluid (CSF) volumes in idiopathic intracranial hypertension (IIH) provide strong evidence that at least two mechanisms are involved in this condition, said Byron L. Lam, MD.

In a prospective study, magnetic resonance imaging (MRI) of 14 newly diagnosed, untreated IIH patients and 11 healthy controls, all women, showed that the mean intracranial CSF volume of IIH patients was significantly greater compared with controls and that the extraventricular space, in particular, was larger in the patient group, said Dr. Lam, professor of ophthalmology, Bascom Palmer Eye Institute, Miami.

The significantly greater extraventricular CSF volume found in the patient group accounted for the increase in the intracranial CSF in that group, a figure that was also significant. However, the ventricular CSF volume was the same between the IIH and control groups.

These findings suggest that decreased CSF absorption and altered venous outflow, both previously suggested as mechanisms of action, coexist in obesity-related IIH.

“If IIH is associated with decreased CSF absorption, increased CSF volume is expected,” Dr. Lam said.

Previous studies suggest that ventricular spaces are larger in IIH, but these reports are limited and inconsistent.

The larger quantitated global cranial CSF volumes in patients compared with controls confirm previous reports that IIH is associated with impaired CSF absorption, while the higher extraventricular volume in the patient group is in line with prior findings on CSF accumulation in the optic nerve sheath as well as lower spinal canal compliance in IIH.

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.